Prevalence, prescription patterns, and quality of life of anaemia in adults with chronic renal disease

Obrazek miniatury
Sandeep, Akkam
Elumalai, Karthikeyan
Williams, Helen
Salkapuram, Sunilkumar
Anandakumar, Shanmugam
Srinivasan, Sivaneswari
Tytuł czasopisma
Tytuł tomu
Publishing Office of the University of Rzeszow
Introduction and aim. Anaemia is a chronic kidney disease (CKD) condition characterised by a decline in glomerular filtration rate (GFR) and impaired kidney function. The aim of this study was to assess the prevalence, prescribing patterns, and quality of life of anaemia in patients with chronic renal disease who were adults (>18 years of age) at a tertiary care hospital. Material and methods. Data on demographic characteristics, laboratory results, medication prescriptions, and quality of life assessments were collected. Statistical tests were performed to determine associations between anaemia prevalence and factors like age, gender, and CKD stage. The study included 132 patients, with a gender distribution of 89 men and 43 women. Results. The most frequently prescribed drugs are epoetin (15.06%), multivitamins (14.82%), iron (10.65%), folic acid (10.22%), calcium carbonate (8.17%), calcitriol (5.6%), and omeprazole (4.22%). The cardiovascular system, blood disorders, and blood-producing organs come after the gastrointestinal tract and metabolism in the first anatomical level of the ATC classification. Conclusion. It suggests hospital audits and recommendations for improved prescription practices. Further investigation into anaemia causes and drug class appropriateness is needed, and implementing improvements could potentially improve health outcomes.
The Raghavendra Institute of Pharmaceutical Education and Research Institution Review Board gave its approval for this study, and it also obtained data usage permission. The study period was November 2022 to April 2023 (date of approval: October 22, 2022, RIPER/IRB/2022/045).
Słowa kluczowe
anaemia , chronic kidney disease , prescribing pattern , quality of life
European Journal of Clinical and Experimental Medicine T. 21, z. 4 (2023), s. 785–792